Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)



Status:Enrolling by invitation
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - 80
Updated:11/11/2018
Start Date:May 12, 2017
End Date:April 15, 2021

Use our guide to learn which trials are right for you!

This study is a prospective, phase 2 extension study of participants previously enrolled in
NTMT-01 and of participants enrolled in NTMT-02. This study is designed to evaluate long term
safety and efficacy of the NT-501 implant in participants previously enrolled in the NTMT-01
and NTMT-02 protocols.


Inclusion Criteria:

- Previously enrolled in the NTMT-01 or NTMT-02 protocol and received the NT-501 implant
and/or underwent a Sham procedure

- Participant must be offered sufficient opportunity to review and to understand the
informed consent form, agree to the form's contents, and provide written informed
consent.

Exclusion Criteria:

- There are no Exclusion Criteria
We found this trial at
9
sites
Cleveland, Ohio 44130
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ann Arbor, Michigan 48105
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
243 Charles St
Boston, Massachusetts 02114
(617) 523-7900
Massachusetts Eye & Ear Infirmary Whether you see our physicians at Mass. Eye and Ear's...
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Madison, WI
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
Rockville, Maryland 20892
?
mi
from
Rockville, MD
Click here to add this to my saved trials
8 Macquarie Street
Sydney, New South Wales 2000
?
mi
from
Sydney,
Click here to add this to my saved trials